SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 2173829

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 2173829

Global Cell Cryopreservation Consumables Market Size, Share, Trends & Growth Analysis Report 2026-2034

PUBLISHED:
PAGES: 202 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3920
PDF & Excel (10-user License)
USD 4730
PDF & Excel (Corporate User License)
USD 7430

Add to Cart

The global cell cryopreservation consumables market size is expected to reach USD 5.28 Billion in 2034 from USD 1.98 Billion in 2025, growing at a CAGR of 11.51% during 2026-2034.This market is experiencing significant growth as biotechnology, pharmaceutical, and biomedical research industries increasingly depend on reliable cell preservation technologies. Cell cryopreservation consumables include specialized freezing media, cryogenic storage vials, tubes, bags, and other materials used to preserve biological samples at extremely low temperatures. Growing demand for cell-based research, regenerative medicine, stem cell banking, and biopharmaceutical development is supporting market expansion. Additionally, increasing investments in biotechnology infrastructure and the development of advanced cell and gene therapies are strengthening demand for specialized cryopreservation products.

The major growth drivers include expanding cell therapy research, rising demand for biobanking services, and increasing adoption of stem cell preservation. Technological advancements in cryoprotective agents, chemically defined freezing media, and sterile single-use storage containers are improving cell viability and preservation reliability. Furthermore, the growing production of vaccines, biologics, and cellular therapeutics is increasing the need for high-quality cryopreservation consumables. Research laboratories, pharmaceutical companies, academic institutions, and clinical facilities are investing in advanced preservation materials to maintain biological sample integrity.

The future prospects of this market remain highly favorable as cell-based therapies and personalized medicine continue to advance. Increasing clinical research involving stem cells, immune cells, and engineered cellular products is expected to generate sustained demand. Innovations in serum-free cryopreservation media, automated sample handling, and advanced storage materials will further improve product performance. Additionally, expanding biobanking infrastructure and increasing investments in regenerative medicine are likely to create new opportunities. Manufacturers focusing on regulatory compliance, sterility, and reliable cell recovery performance will remain important market participants.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

  • Cryogenic Vials
  • Cryogenic Tubes
  • Cryopreservation Bags
  • Cryogenic Straws
  • Cryogenic Plates
  • Others

By Cell Type

  • Stem Cells
  • Immune Cells
  • Primary Cells
  • Cancer Cells
  • Reproductive Cells
  • Other Cells

By End Use

  • Biopharmaceutical & Biotechnology Companies
  • Research & Academic Institutes
  • Hospitals & Clinics
  • Cell Banks & Biobanks
  • Others

COMPANIES PROFILED

  • Corning Incorporated
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Azenta US Inc.
  • Greiner Bio-One International GmbH
  • Saint-Gobain
  • OriGen Biomedical Inc.
  • CellBios
  • Miltenyi Biotec
  • Pluristyx Inc.
  • BioLife Solutions Inc.
  • HOH Cells
  • Sartorius AG
  • STEMCELL Technologies Inc.
  • Cytiva
  • FUJIFILM Biosciences
  • Danaher Corporation
  • Lonza Group Ltd.
  • Eppendorf SE
  • Cryoport Inc.
Product Code: VMR112119927

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CELL CRYOPRESERVATION CONSUMABLES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Cryogenic Vials Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Cryogenic Tubes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Cryopreservation Bags Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Cryogenic Straws Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Cryogenic Plates Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CELL CRYOPRESERVATION CONSUMABLES MARKET: BY CELL TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Cell Type
  • 5.2. Stem Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Immune Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Primary Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Cancer Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Reproductive Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Other Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CELL CRYOPRESERVATION CONSUMABLES MARKET: BY END USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End Use
  • 6.2. Biopharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Research & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Cell Banks & Biobanks Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CELL CRYOPRESERVATION CONSUMABLES MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Cell Type
    • 7.2.3 By End Use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Cell Type
    • 7.3.3 By End Use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Spain
    • 7.3.9 Russia
    • 7.3.10 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Cell Type
    • 7.4.3 By End Use
    • 7.4.4 China
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 India
    • 7.4.8 Australia
    • 7.4.9 South East Asia
    • 7.4.10 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Cell Type
    • 7.5.3 By End Use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Cell Type
    • 7.6.3 By End Use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CELL CRYOPRESERVATION CONSUMABLES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Corning Incorporated
    • 9.2.2 Thermo Fisher Scientific Inc
    • 9.2.3 Merck KGaA
    • 9.2.4 Azenta US Inc
    • 9.2.5 Greiner Bio-One International GmbH
    • 9.2.6 Saint-Gobain
    • 9.2.7 OriGen Biomedical Inc
    • 9.2.8 CellBios
    • 9.2.9 Miltenyi Biotec
    • 9.2.10 Pluristyx Inc
    • 9.2.11 BioLife Solutions Inc
    • 9.2.12 HOH Cells
    • 9.2.13 Sartorius AG
    • 9.2.14 STEMCELL Technologies Inc
    • 9.2.15 Cytiva
    • 9.2.16 FUJIFILM Biosciences
    • 9.2.17 Danaher Corporation
    • 9.2.18 Lonza Group Ltd
    • 9.2.19 Eppendorf SE
    • 9.2.20 Cryoport Inc
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!